ImpediMed
About ImpediMed
ImpediMed is a medical technology company specializing in non-invasive fluid and body composition assessment using Bioimpedance Spectroscopy (BIS) technology. Their flagship product, the SOZO® Digital Health Platform, is FDA-cleared, CE-marked, and ARTG-listed, offering clinicians a precise and rapid (under 30 seconds) method to monitor key health indicators. This technology is particularly valuable for the early detection and management of lymphedema, especially breast cancer-related lymphedema (BCRL), often identifying fluid changes before clinical symptoms manifest.
Beyond lymphedema, the SOZO platform extends its utility to other critical areas. It provides objective fluid status monitoring for patients with heart failure (HF-Dex™ analysis) and offers comprehensive body composition analysis (BodyComp Analysis), which is beneficial for medical weight management, wellness, and addressing protein calorie malnutrition. By generating thousands of unique data points, SOZO enables the creation of individualized baseline readings and facilitates longitudinal tracking, supporting personalized care across the patient journey. The cloud-connected platform seamlessly integrates into existing clinical workflows, providing real-time and historical data for both individual patient management and population-level trend analysis.
Focus Areas
Business Intelligence
| Key Investors | Paradice Investment Management, Australian Ethical Investments Ltd., Regal Funds Management, Starfish Ventures, Versant Ventures |
| Partnerships | AstraZeneca (clinical trials), Mayo Clinic (clinical trial agreement), Legacy Health |
| Technology | SOZO® Digital Health Platform, Bioimpedance Spectroscopy (BIS) technology, cloud-native, AI algorithms, L-Dex® Analysis, BodyComp™ Analysis, HF-Dex® Analysis |
| FDA Clearances | 5 cleared products (estimated) |
What Physicians Need to Know
For physicians, ImpediMed's SOZO Digital Health Platform stands out due to its **FDA-cleared Bioimpedance Spectroscopy (BIS) technology**, which provides objective, non-invasive, and highly accurate measurements of fluid status and tissue composition. The ability to detect subclinical lymphedema with L-Dexu00ae and early fluid shifts in heart failure with HF-Dexu2122 allows for **proactive intervention**, potentially preventing chronic conditions and reducing hospitalizations. The platform is supported by **extensive clinical evidence**, including the PREVENT trial, and is recommended in national clinical practice guidelines (e.g., NCCN, NABPC). Its **ease of use** (30-second scan, performable by any care team member) and **immediate, cloud-connected results** streamline clinical workflow and enable comprehensive, personalized patient care. Furthermore, the availability of a **Category 1 CPT code (93702)** and growing reimbursement coverage from Medicare and private payers enhances patient access to this critical diagnostic tool.
The SOZO Digital Health Platform is designed for seamless integration into existing clinical workflows. Results are instantly available through the MySOZO web-based portal and can be integrated with Electronic Health Records (EHR) for auto-documentation. The system also offers integration into Active Directory and LDAP protocol for user account management.
What the Web Says
ImpediMed receives mixed reviews, with some users praising their L-Dex system for its effectiveness in lymphedema detection and ease of use, particularly in clinical settings. However, there are concerns regarding the company's internal culture, management, and compensation practices, as reflected in employer reviews. Product support is generally seen as adequate, but some wish for more comprehensive training.
Overall: MixedStrengths
- L-Dex system is effective for lymphedema detection
- Easy to use and integrate into clinical workflows
- Provides objective data for patient management
- Helpful for early intervention in lymphedema
- Good for monitoring patient progress
- Some users find the technology innovative
Limitations
- Internal company culture issues reported by employees
- Concerns about management and leadership decisions
- Compensation and benefits may not be competitive
- Limited career growth opportunities for some roles
- Product training could be more comprehensive
- Some reports of high employee turnover
Based on reviews from: Glassdoor, G2, Reddit, Capterra, Healthcare IT News (general industry sentiment)
Last updated: 2026-07-18
Videos
News, demos, and interviews about ImpediMed.
Videos load interactively. If none appear, search YouTube for ImpediMed →
Press & Coverage
Frequently Asked Questions
Comparisons
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]